Group One Trading’s Enzo Biochem, Inc. ENZ Stock Holding History

Group One Trading’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,100	Closed	-$25.2K	–	8132
2023 Q4	$25.2K	Sell	18,100 -29,300	-62%	-$38.9K	﹤0.01%	5575
2023 Q3	$66.4K	Buy	47,400 +2,900	+7%	+$4.37K	﹤0.01%	4840
2023 Q2	$81.9K	Sell	44,500 -45,000	-50%	-$104K	﹤0.01%	4813
2023 Q1	$217K	Buy	+89,500	New	+$133K	﹤0.01%	3589
2022 Q4	–	Sell	-48,200	Closed	-$107K	–	8252
2022 Q3	$107K	Buy	+48,200	New	+$116K	﹤0.01%	4718
2022 Q2	–	Sell	-31,000	Closed	-$90K	–	8673
2022 Q1	$90K	Buy	31,000 +12,500	+68%	+$40.1K	﹤0.01%	5593
2021 Q4	$59K	Sell	18,500 -30,000	-62%	-$102K	﹤0.01%	6195
2021 Q3	$172K	Buy	48,500 +24,400	+101%	+$81.4K	﹤0.01%	5337
2021 Q2	$76K	Sell	24,100 -17,300	-42%	-$54.4K	﹤0.01%	6214
2021 Q1	$142K	Sell	41,400 -43,300	-51%	-$135K	﹤0.01%	5336
2020 Q4	$213K	Buy	84,700 +61,700	+268%	+$134K	﹤0.01%	4013
2020 Q3	$49K	Sell	23,000 -3,700	-14%	-$8.79K	﹤0.01%	4662
2020 Q2	$60K	Sell	26,700 -24,500	-48%	-$63K	﹤0.01%	4251
2020 Q1	$130K	Buy	+51,200	New	+$126K	﹤0.01%	3093
2019 Q3	–	Sell	-51,700	Closed	-$174K	–	5644
2019 Q2	$174K	Buy	51,700 +49,400	+2,148%	+$174K	﹤0.01%	2966
2019 Q1	$6K	Buy	+2,300	New	+$7.53K	﹤0.01%	4412
2018 Q4	–	Sell	-85,000	Closed	-$350K	–	5510
2018 Q3	$350K	Buy	85,000 +12,800	+18%	+$58.1K	﹤0.01%	2586
2018 Q2	$375K	Sell	72,200 -20,300	-22%	-$124K	﹤0.01%	2541
2018 Q1	$507K	Buy	92,500 +6,600	+8%	+$46.5K	0.01%	2055
2017 Q4	$700K	Buy	+85,900	New	+$820K	﹤0.01%	1978
2017 Q3	–	Sell	-29,200	Closed	-$322K	–	5232
2017 Q2	$322K	Buy	29,200 +3,400	+13%	+$31.7K	﹤0.01%	2298
2017 Q1	$216K	Sell	25,800 -26,300	-50%	-$185K	﹤0.01%	2474
2016 Q4	$362K	Sell	52,100 -1,400	-3%	-$8.94K	﹤0.01%	1995
2016 Q3	$272K	Buy	53,500 +11,400	+27%	+$68.1K	﹤0.01%	2262
2016 Q2	$251K	Sell	42,100 -40,600	-49%	-$225K	﹤0.01%	2249
2016 Q1	$376K	Buy	82,700 +24,800	+43%	+$110K	0.01%	1890
2015 Q4	$261K	Buy	57,900 +37,400	+182%	+$158K	﹤0.01%	2295
2015 Q3	$65K	Hold	20,500	–	–	﹤0.01%	3367
2015 Q2	$62K	Buy	20,500 +12,600	+159%	+$35.4K	﹤0.01%	3408
2015 Q1	$23K	Buy	7,900 +6,100	+339%	+$20K	﹤0.01%	3824
2014 Q4	$8K	Sell	1,800 -56,300	-97%	-$268K	﹤0.01%	4310
2014 Q3	$299K	Sell	58,100 -2,400	-4%	-$12.8K	﹤0.01%	2039
2014 Q2	$318K	Buy	60,500 +59,700	+7,463%	+$258K	﹤0.01%	2010
2014 Q1	$3K	Buy	+800	New	+$2.74K	﹤0.01%	4939
2013 Q4	–	Sell	-1,200	Closed	-$3K	–	5601
2013 Q3	$3K	Buy	1,200 +900	+300%	+$2.13K	﹤0.01%	4907
2013 Q2	$1K	Buy	+300	New	+$662	﹤0.01%	4976

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's ENZ Position: Q1 2023 in Review

Group One Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 27,996 shares — an estimated $41.6K sold.

Group One Trading first reported a position in ENZ in Q3 2013 and held it in 19 quarters. The position peaked at $920K in Q2 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

Group One Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
Group One Trading sold 27,996 Enzo Biochem, Inc. shares in Q1 2023, an estimated $41.6K.
Group One Trading first reported a position in Enzo Biochem, Inc. in Q3 2013 and held it in 19 quarters.
Group One Trading's Enzo Biochem, Inc. position peaked at $920K in Q2 2021.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.